Topical Cantharidin Revisited: A Phase 2 Study Investigating a Commercially-Viable Formulation of Cantharidin (VP-102) for the Treatment of Molluscum Contagiosum

نویسندگان

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Treatment of molluscum contagiosum with cantharidin: a practical approach.

Molluscum contagiosum is very common. In this article we discuss the use of cantharidin as a treatment option for molluscum contagiosum and give detailed information about distribution sources, how to apply it, and caveats regarding its use.Molluscum contagiosum is a common viral disease of childhood caused by a poxvirus, which presents with small, firm, dome-shaped, umbilicated papules. It is ...

متن کامل

investigating the feasibility of a proposed model for geometric design of deployable arch structures

deployable scissor type structures are composed of the so-called scissor-like elements (sles), which are connected to each other at an intermediate point through a pivotal connection and allow them to be folded into a compact bundle for storage or transport. several sles are connected to each other in order to form units with regular polygonal plan views. the sides and radii of the polygons are...

[Curettage for the treatment of molluscum contagiosum: a descriptive study].

Careful consideration must be given to the possibility of occult neoplasms in dermatomyositis in middle-aged to elderly patients.3,8,9 The most common cancers found in association with dermatomyositis are ovarian, pancreatic, and lung cancers. We have presented a case of dermatomyositis associated with cancer of the lung and presenting livedo reticulated ulcers due to livedoid vasculopathy. We ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: SKIN The Journal of Cutaneous Medicine

سال: 2018

ISSN: 2574-1624

DOI: 10.25251/skin.2.supp.98